M3-Brigade Acquisition VI Corp.

For the period ended Jun 30, 2025. Filed Oct 8, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Oct 8, 2025

MBVI$10.280.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Item 6. Exhibits

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

No.	Description of Exhibit
1.1*	Underwriting Agreement, dated August 26, 2025, between the Company and Cantor, as representative of the underwriters.
3.1*	Amended and Restated Memorandum and Articles of Association.
4.1*	Warrant Agreement, dated August 26, 2025, between the Company and Continental Stock Transfer & Trust Company, as warrant agent
10.1*	Letter Agreement, dated August 26, 2025, among the Company and the Company’s officers and directors and the Sponsor.
10.2*	Investment Management Trust Agreement, dated August 26, 2025, between the Company and Continental Stock Transfer & Trust Company, as trustee.
10.3*	Registration Rights Agreement, dated August 26, 2025, among the Company and certain security holders.
10.4*	Private Placement Warrants Purchase Agreement, dated August 26, 2025, between the Company and the Sponsor.
10.5*	Private Placement Warrants Purchase Agreement, dated August 26, 2025, between the Company and Cantor.
10.6*	Indemnity Agreement, dated August 26, 2025, between the Company and Mohsin Meghji.
10.7*	Indemnity Agreement, dated August 26, 2025, between the Company and Matthew Perkal.
10.8*	Indemnity Agreement, dated August 26, 2025, between the Company and Chris Chaice.
10.9*	Indemnity Agreement, dated August 26, 2025, between the Company and Eric Greenhaus.
10.10*	Indemnity Agreement, dated August 26, 2025, between the Company and Charles Garner.
10.11*	Indemnity Agreement, dated August 26, 2025, between the Company and Benjamin Fader-Rattner.
31.1**	Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2**	Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1***	Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2***	Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS	Inline XBRL Instance Document.
101.SCH	Inline XBRL Taxonomy Extension Schema Document.
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

*	Previously filed as an exhibit to our Current Report on Form 8-K filed September 2, 2025 and incorporated herein by reference.
**	Filed herewith.
***	These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.